CRMD CorMedix Inc.
Healthcare$8.27+3.63%ClosedMarket Cap: $648.8M
As of 2026-05-26
Valuation
P/E (TTM)
3.51
PEG
0.00
P/B
1.45
P/S
1.56
EV/EBITDA
2.69
DCF Value
$2.47
FCF Yield
31.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
85.8%
Operating Margin
48.4%
Net Margin
45.2%
ROE
50.4%
ROA
22.2%
ROIC
27.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $127.4M | 82.5% | $63.7M | $38.6M | $— | — |
| Q4 null | $128.6M | 83.4% | $59.1M | $14.0M | $— | — |
| FY null | $311.7M | 88.5% | $150.1M | $163.1M | $— | — |
| Q3 null | $104.3M | 89.3% | $51.3M | $108.6M | $— | — |
| Q2 null | $39.7M | 95.3% | $19.5M | $19.8M | $— | — |
| Q1 null | $39.1M | 95.9% | $20.1M | $20.6M | $— | — |
| Q4 null | $31.2M | 96.2% | $12.9M | $13.5M | $— | — |
| FY null | $43.5M | 92.7% | $-22.4M | $-17.9M | $— | — |
| Q3 null | $11.5M | 94.0% | $-3.3M | $-2.8M | $— | — |
| Q2 null | $806.1K | 36.8% | $-15.3M | $-14.2M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-16.7M | $-14.5M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-15.7M | $-14.8M | $-0.26 | — |